Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

October 18 We're pleased to welcome our newest partner, Jan Bauer. https://t.co/58nUVX9kQS
October 17 Spotlight on No-Poach Agreements Continues, Expands to New Industries skadden.com/insights/publi…
October 17 Planning for Merger Reviews and Antitrust Inquiries in Case of a 'No-Deal' Brexit skadden.com/insights/publi…